相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer
P. Schmid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Hallmarks of Cancer: New Dimensions
Douglas Hanahan
CANCER DISCOVERY (2022)
Potential Predictive and Prognostic Value of Biomarkers Related to Immune Checkpoint Inhibitor Therapy of Triple-Negative Breast Cancer
Qiaorui Tan et al.
FRONTIERS IN ONCOLOGY (2022)
Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer
J. Cortes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Simulations of tumor growth and response to immunotherapy by coupling a spatial agentbased model with a whole-patient quantitative systems pharmacology model
Alvaro Ruiz-Martinez et al.
PLOS COMPUTATIONAL BIOLOGY (2022)
Dynamics of tumor-associated macrophages in a quantitative systems pharmacology model of immunotherapy in triple-negative breast cancer
Hanwen Wang et al.
ISCIENCE (2022)
Quantitative Spatial Profiling of Immune Populations in Pancreatic Ductal Adenocarcinoma Reveals Tumor Microenvironment Heterogeneity and Prognostic Biomarkers
Haoyang Mi et al.
CANCER RESEARCH (2022)
Quantitative Systems Pharmacology Approaches for Immuno-Oncology: Adding Virtual Patients to the Development Paradigm
Vijayalakshmi Chelliah et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)
Beyond the single average tumor: Understanding IO combinations using a clinical QSP model that incorporates heterogeneity in patient response
Rukmini Kumar et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2021)
Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination
Jiali Yu et al.
NATURE MEDICINE (2021)
Pembrolizumab versus investigator-choice chemotherapy for metastatic triple-negative breast cancer (KEYNOTE-119): a randomised, open-label, phase 3 trial
Eric P. Winer et al.
LANCET ONCOLOGY (2021)
Quantitative systems pharmacology model predictions for efficacy of atezolizumab and nab-paclitaxel in triple-negative breast cancer
Hanwen Wang et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Novel temporal and spatial patterns of metastatic colonization from breast cancer rapid-autopsy tumor biopsies
Xiaomeng Huang et al.
GENOME MEDICINE (2021)
History and Future Perspectives on the Discipline of Quantitative Systems Pharmacology Modeling and Its Applications
Karim Azer et al.
FRONTIERS IN PHYSIOLOGY (2021)
Genomic and Transcriptomic Analyses of Breast Cancer Primaries and Matched Metastases in AURORA, the Breast International Group (BIG) Molecular Screening Initiative
Philippe Aftimos et al.
CANCER DISCOVERY (2021)
A Spatial Quantitative Systems Pharmacology Platform spQSP-IO for Simulations of Tumor-Immune Interactions and Effects of Checkpoint Inhibitor Immunotherapy
Chang Gong et al.
CANCERS (2021)
Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden, humoral immunity and long-term survivorship in pancreatic cancer
Andrew J. Gunderson et al.
ONCOIMMUNOLOGY (2021)
Compartmental Analysis of T-cell Clonal Dynamics as a Function of Pathologic Response to Neoadjuvant PD-1 Blockade in Resectable Non-Small Cell Lung Cancer
Jiajia Zhang et al.
CLINICAL CANCER RESEARCH (2020)
Integration of Omics Data Sources to Inform Mechanistic Modeling of Immune-Oncology Therapies: A Tutorial for Clinical Pharmacologists
Georgia Lazarou et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
Conducting a Virtual Clinical Trial in HER2-Negative Breast Cancer Using a Quantitative Systems Pharmacology Model With an Epigenetic Modulator and Immune Checkpoint Inhibitors
Hanwen Wang et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2020)
Cytokines secreted by stromal cells in TNBC microenvironment as potential targets for cancer therapy
Marie K. Malone et al.
CANCER BIOLOGY & THERAPY (2020)
TIMER2.0 for analysis of tumor-infiltrating immune cells
Taiwen Li et al.
NUCLEIC ACIDS RESEARCH (2020)
A Quantitative Systems Pharmacology Model of T Cell Engager Applied to Solid Tumor
Huilin Ma et al.
AAPS JOURNAL (2020)
Lung metastases share common immune features regardless of primary tumor origin
Sandra Garcia-Mulero et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
A QSP model of prostate cancer immunotherapy to identify effective combination therapies
Roberta Coletti et al.
SCIENTIFIC REPORTS (2020)
Combination therapy with T cell engager and PD-L1 blockade enhances the antitumor potency of T cells as predicted by a QSP model
Huilin Ma et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Regulatory T cell control of systemic immunity and immunotherapy response in liver metastasis
James C. Lee et al.
SCIENCE IMMUNOLOGY (2020)
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial
Javier Cortes et al.
LANCET (2020)
Therapeutic strategies to remodel immunologically cold tumors
Minyu Wang et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2020)
Relationship between tumor-infiltrating lymphocytes (TILs) and outcomes in the KEYNOTE-119 study of pembrolizumab vs chemotherapy for previously treated metastatic triple-negative breast cancer (mTNBC)
Sherene Loi et al.
CANCER RESEARCH (2020)
Molecular principles of metastasis: a hallmark of cancer revisited
Jawad Fares et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
The neoepitope landscape of breast cancer: implications for immunotherapy
Pooja Narang et al.
BMC CANCER (2019)
Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data
Francesca Finotello et al.
GENOME MEDICINE (2019)
In silico simulation of a clinical trial with anti-CTLA-4 and anti-PD-L1 immunotherapies in metastatic breast cancer using a systems pharmacology model
Hanwen Wang et al.
ROYAL SOCIETY OPEN SCIENCE (2019)
A Computational Model of Neoadjuvant PD-1 Inhibition in Non-Small Cell Lung Cancer
Mohammad Jafarnejad et al.
AAPS JOURNAL (2019)
Comprehensive evaluation of transcriptome-based cell-type quantification methods for immuno-oncology
Gregor Sturm et al.
BIOINFORMATICS (2019)
LBA21KEYNOTE-119: Phase III study of pembrolizumab (pembro) versus single-agent chemotherapy (chemo) for metastatic triple negative breast cancer (mTNBC)
J Cortés et al.
ANNALS OF ONCOLOGY (2019)
Long-term Clinical Outcomes and Biomarker Analyses of Atezolizumab Therapy for Patients With Metastatic Triple-Negative Breast Cancer A Phase 1 Study
Leisha A. Emens et al.
JAMA ONCOLOGY (2019)
A QSP Model for Predicting Clinical Responses to Monotherapy, Combination and Sequential Therapy Following CTLA-4, PD-1, and PD-L1 Checkpoint Blockade
Oleg Milberg et al.
SCIENTIFIC REPORTS (2019)
Pembrolizumab monotherapy for previously untreated, PD-L1-positive, metastatic triple-negative breast cancer: cohort B of the phase II KEYNOTE-086 study
S. Adams et al.
ANNALS OF ONCOLOGY (2019)
Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study
S. Adams et al.
ANNALS OF ONCOLOGY (2019)
Metastatic breast cancers have reduced immune cell recruitment but harbor increased macrophages relative to their matched primary tumors
Li Zhu et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Tumor immune microenvironment and genomic evolution in a patient with metastatic triple negative breast cancer and a complete response to atezolizumab
Luciana Molinero et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Cold Tumors: A Therapeutic Challenge for Immunotherapy
Paola Bonaventura et al.
FRONTIERS IN IMMUNOLOGY (2019)
Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer
Florian Posch et al.
ONCOIMMUNOLOGY (2018)
Integrated RNA and DNA sequencing reveals early drivers of metastatic breast cancer
Marni B. Siegel et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Immunological differences between primary and metastatic breast cancer
B. Szekely et al.
ANNALS OF ONCOLOGY (2018)
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
P. Schmid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
High-resolution clonal mapping of multi-organ metastasis in triple negative breast cancer
Gloria V. Echeverria et al.
NATURE COMMUNICATIONS (2018)
Spatially and functionally distinct subclasses of breast cancer-associated fibroblasts revealed by single cell RNA sequencing
Michael Bartoschek et al.
NATURE COMMUNICATIONS (2018)
Immune checkpoint inhibitors: recent progress and potential biomarkers
Pramod Darvin et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2018)
Germinal Centers Determine the Prognostic Relevance of Tertiary Lymphoid Structures and Are Impaired by Corticosteroids in Lung Squamous Cell Carcinoma
Karina Silina et al.
CANCER RESEARCH (2018)
Monocytic and granulocytic myeloid derived suppressor cells differentially regulate spatiotemporal tumour plasticity during metastatic cascade
Maria Ouzounova et al.
NATURE COMMUNICATIONS (2017)
Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data
Julien Racle et al.
ELIFE (2017)
xCell: digitally portraying the tissue cellular heterogeneity landscape
Dvir Aran et al.
GENOME BIOLOGY (2017)
Deep phenotyping of Tregs identifies an immune signature for idiopathic aplastic anemia and predicts response to treatment
Shahram Kordasti et al.
BLOOD (2016)
PD-L1 (B7-H1) expression and the immune tumor microenvironment in primary and metastatic breast carcinomas
Ashley Cimino-Mathews et al.
HUMAN PATHOLOGY (2016)
Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study
Rita Nanda et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
The promises of quantitative systems pharmacology modelling for drug development
V. R. Knight-Schrijver et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2016)
Efficient Generation and Selection of Virtual Populations in Quantitative Systems Pharmacology Models
R. J. Allen et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2016)
Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression
Etienne Becht et al.
GENOME BIOLOGY (2016)
The biology and function of fibroblasts in cancer
Raghu Kalluri
NATURE REVIEWS CANCER (2016)
Comprehensive analyses of tumor immunity: implications for cancer immunotherapy
Bo Li et al.
GENOME BIOLOGY (2016)
The landscape of metastatic progression patterns across major human cancers
Jan Budczies et al.
ONCOTARGET (2015)
Surviving at a Distance: Organ-Specific Metastasis
Anna C. Obenauf et al.
TRENDS IN CANCER (2015)
Antigen affinity, costimulation, and cytokine inputs sum linearly to amplify T cell expansion
Julia M. Marchingo et al.
SCIENCE (2014)
Metastatic triple-negative breast cancers at first relapse have fewer tumor-infiltrating lymphocytes than their matched primary breast tumors: a pilot study
Ashley Cimino-Mathews et al.
HUMAN PATHOLOGY (2013)
Analysis of pattern, time and risk factors influencing recurrence in triple-negative breast cancer patients
Katarzyna Pogoda et al.
MEDICAL ONCOLOGY (2013)
Cancer Immunotherapy Comes of Age
Suzanne L. Topalian et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Triple-Negative Breast Cancer
William D. Foulkes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Sites of Distant Recurrence and Clinical Outcomes in Patients With Metastatic Triple-negative Breast Cancer High Incidence of Central Nervous System Metastases
Nancy U. Lin et al.
CANCER (2008)
The triple negative paradox: Primary tumor chemosensitivity of breast cancer subtypes
Lisa A. Carey et al.
CLINICAL CANCER RESEARCH (2007)
Tumor metastasis: mechanistic insights and clinical challenges
Patricia S. Steeg
NATURE MEDICINE (2006)
分享论文
